Bened Biomedical Co., Ltd.

Bened Biomedical (est. 2015) is a global leader in psychobiotics, with products in
60+ countries. Its flagship strain, PS128TM,
is the world’s first probiotic proven to modulate brain dopamine, supporting
those with autism, Parkinson’s, and depression. Bened fills medical gaps
through rigorous microbiome R&D.

• Clinical Trial Collaboration
• ODM/OEM
• Out-Licensing
• CDMO
• In-Licensing
• CRO
• Collaborative R&D
• Distribution
• Co-Development
• Strategic Alliance